Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
CLLS: 185% | Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca
TGTX: 28% | TG Therapeutics GAAP EPS of $0.73 beats by $0.56, revenue of $165.82M beats by $102.48M